Results 31 to 40 of about 7,577 (154)
ABSTRACT Effective chemotherapy for canine histiocytic sarcoma (CHS) has yet to be established. In our previous study, CHS cell lines were subclassified into two groups based on their gene expression profiles: Group A and Group B. This study aimed to identify novel therapeutic agents that are effective against each CHS subgroup, and we performed high ...
Hiroki Sakuma +6 more
wiley +1 more source
Antioxidant supplementation in cancer: Potential interactions with conventional chemotherapy and radiation therapy [PDF]
Several issues are addressed in this discussion of the advantages and disadvantages of supplemental anti-oxidants during cancer treatment with chemotherapy and/or radiation ...
Staff, Clinic
core +1 more source
What's new? While the effectiveness of systemic anticancer therapy is well documented, it commonly causes severe toxicity. This study of the 467 systemic anticancer therapy agents currently approved globally for clinical and/or research purposes found that peripheral neurotoxicity is associated with 45% of classical chemotherapies, 21% of targeted ...
Cassie Higgins +3 more
wiley +1 more source
Subsequent pregnancies after a diagnosis of pregnancy‐associated cancer
Approximately 1 in 15 women diagnosed with pregnancy‐associated cancer went on to have a subsequent pregnancy, with markedly higher probabilities in those diagnosed before the age of 35 and those who did not undergo antineoplastic treatments. Abstract Introduction Pregnancy‐associated cancer is a rare but clinically significant event.
Giovanna Esposito +7 more
wiley +1 more source
The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population [PDF]
BACKGROUND: Prevalence of nonalcoholic fatty liver disease (NAFLD) and rate of advanced fibrosis among individuals with metabolic syndrome (MetS) and its individual metabolic abnormalities needs better understanding in the United States population. We
Antaki, Fadi +3 more
core +1 more source
Periocular Pigmentation After Gemcitabine Monotherapy for Bladder Cancer: A Rare Case Report
ABSTRACT A patient with advanced bladder cancer received antitumor therapy consisting of gemcitabine on days 1 and 8 combined with cisplatin and treliprimab on day 1. Severe periorbital hyperpigmentation occurred 30 min after gemcitabine infusion on day 8. Symmetrical diffuse hyperpigmentation of a dark brown hue with indistinct borders appeared around
Li Juan, Chen Weiping
wiley +1 more source
Oral considerations in pediatric patients with acute lymphoblastic leukemia [PDF]
Introduction: Acute lymphocytic leukemia is one of the most common type of cancer in children and it is characterized by excessive and disordered immature leukocytes in the bone marrow.
Aroso, Ricardo
core
Improving therapeutic ratio In head and neck cancer with adjuvant and cisplatin-based treatments [PDF]
Advanced head and neck cancers are difficult to manage despite the large treatment arsenal currently available. The multidisciplinary effort to increase disease-free survival and diminish normal tissue toxicity was rewarded with better locoregional ...
Marcu, L.
core +3 more sources
ABSTRACT This study evaluated the phytochemical composition, antimicrobial activity, and in vivo protective effects of the hydroethanolic extract from Commiphora leptophloeos stem bark (HECL) against 5‐fluorouracil (5‐FU)‐induced intestinal mucositis. Despite the extensive traditional use of C.
Stphannie Jamyla de Araújo Barbosa +17 more
wiley +1 more source
Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects [PDF]
Mesenchymal stem cells (MSCs) are able to infiltrate tumor tissues and thereby effectively deliver gene therapeutic payloads. Here, we engineered murine MSCs (mMSCs) to express a secreted form of the TNF-related apoptosis-inducing ligand (TRAIL), which ...
A Ashkenazi +46 more
core +1 more source

